AstraZeneca Annual Report and Financial Statements 80 Form 20-F Information 2003 Notes to the Financial Statements continued 16 Other creditors 2003 2002 $m $m Amounts due within one year Trade creditors 3,086 3,171 Corporate taxation 1,353 1,191 Value added and payroll taxes and social security 255 167 Other creditors 946 1,507 Accruals 989 855 Dividends to shareholders 914 808 7,543 7,699 Amounts due after more than one year Other creditors 52 34 Included in other creditors are amounts totalling $59m 2002 $189m to meet insurance obligations of the Groups insurance subsidiaries.
Also in other creditors are amounts due within one year in connection with the Groups exceptional charges including $54m 2002 $61m in respect of the Agrochemicals demerger and Specialties disposal.
17 Loans Repayment 2003 2002 dates $m $m Secured loans Secured by fixed charge 2007 19 Total secured 19 Unsecured loans US dollars 6.3% Guaranteed notes 2003 284 7% Guaranteed debentures 2023 295 295 Others 2003 2013 8 44 Total unsecured 303 623 Total loans 303 642 Less: current instalments of loans 314 Loans due after more than one year 303 328 In the above table loans are shown after taking account of associated cross-currency swaps see Note 18.
Loans from banks included in the table above amounted to $nil 2002 $40m of which $nil 2002 $19m was secured.
